News Sentiment

BTMD sentiment intelligence

biote Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 2.33 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+7.4% over one week, -5.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Price to earnings forward of Biote Corp. – NASDAQ:BTMD

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 7.4% Price confirming higher
Trend fit Trend inactive -5.3% over four weeks
Fair value -47.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 38
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 18
TradingView 4
dars.gov.et 3
marketscreener.com 3
Market source 3
Simply Wall Street 2
Investing.com 2
DonanımHaber 1

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 11
Regulatory and legal 6
Guidance 4
Deals and strategy 2
Balance sheet 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 54
TradingView Direct company coverage

biote Corp. Class A Actuals & Estimates (NASDAQ:BTMD)

This article provides an overview of Biote Corp. (NASDAQ: BTMD) stock, including its current price, historical performance, analyst forecasts, volatility, market capitalization, and financial results. It details recent earnings and revenue, upcoming earnings dates, and confirms t

Tone
Negative 36/100
Event
Earnings
Published
26 Jun 2026 06:41
Source
TradingView
Stock Titan Direct company coverage

biote Corp. (BTMD) interim CEO receives 206,746 stock options at $2.46 strike

biote Corp.'s interim CEO, Robert Charles Peterson, was granted 206,746 stock options with an exercise price of $2.46 per share, set to expire on June 11, 2036. The options will vest over time, with 25% vesting on June 12, 2027, and the remainder vesting in 36 equal monthly insta

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

biote Corp. (BTMD) director receives 130,000 stock options at $2.34 strike

biote Corp. director Bret Christensen was granted 130,000 stock options with an exercise price of $2.34 per share, expiring on June 7, 2036. These options will vest on the earlier of June 8, 2027, or the day before the company's 2027 Annual Meeting, provided Christensen remains i

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

biote Corp. (BTMD) Executive Chairman receives 114,157 stock options at $2.34

biote Corp.'s Executive Chairman, Marc D. Beer, was granted 114,157 employee stock options with an exercise price of $2.34 per share, expiring on June 7, 2036. These options will vest over time, with 25% vesting on June 8, 2027, and the remaining 75% vesting in 36 equal monthly i

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 21:10
Source
Stock Titan
Stock Titan Direct company coverage

Biote (NASDAQ: BTMD) names interim CEO, appoints Executive Chairman and reaffirms 2026 outlook

Biote (NASDAQ: BTMD) announced a leadership transition, naming Robert Peterson as Interim CEO and Marc Beer as Executive Chairman, following Bret Christensen's resignation for personal reasons. The company reaffirmed its full-year 2026 guidance, expecting revenue above $190 milli

Tone
Neutral 50/100
Event
Guidance
Published
02 Jun 2026 23:10
Source
Stock Titan
Simply Wall Street Direct company coverage

biote Corp. (BTMD) - Regulatory Tailwind Meets Operational Reset: A Mispriced Recovery

This article analyzes biote Corp. (BTMD), a hormone optimization company, highlighting its potential for recovery driven by regulatory changes and operational improvements. The removal of the FDA black box warning for compounded testosterone products is seen as a key catalyst, ex

Tone
Positive 74/100
Event
Regulatory and legal
Published
24 May 2026 20:38
Source
Simply Wall Street
Stock Titan Direct company coverage

biote Corp. (NASDAQ: BTMD) investors back board nominees and Deloitte as 2026 auditor

Biote Corp. shareholders have elected Andrew R. Heyer and Dana Jacoby as Class I directors to serve until the 2029 annual meeting. The stockholders also ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 202

Tone
Neutral 50/100
Event
Market update
Published
18 May 2026 20:09
Source
Stock Titan
FinancialContent Direct company coverage

Dow Theory Letters - Biote Corp. - Class A common stock (Nasdaq:BTMD) Stock Quote

This article provides a stock quote and recent news for Biote Corp. (Nasdaq: BTMD). It includes current trading information, financial performance data, and a list of press releases and earnings call transcripts from various sources. The stock was trading at $1.910, down 3.05% at

Tone
Neutral 50/100
Event
Earnings
Published
15 May 2026 15:08
Source
FinancialContent
Stock Titan Direct company coverage

biote Corp. (BTMD) director Andrew Heyer receives options and 35,259 deferred RSUs

biote Corp. director Andrew Heyer was granted equity-based compensation awards, including stock options for 130,000 shares of Class A Common Stock with an exercise price of $2.20 and 35,259 Deferred Settlement RSUs. The stock options will vest on the earlier of May 12, 2027, or t

Tone
Neutral 50/100
Event
Market update
Published
14 May 2026 20:38
Source
Stock Titan
Stock Titan Direct company coverage

biote Corp. (BTMD) grants options and RSUs to director

Bioten Corp. (BTMD) director Stephen Mark Cone has been granted 130,000 stock options at an exercise price of $2.20 per share, vesting by May 2027. He also received 31,481 Deferred Settlement RSUs, which are immediately vested but deferred until his separation from service. These

Tone
Neutral 50/100
Event
Market update
Published
14 May 2026 14:39
Source
Stock Titan
Stock Titan Direct company coverage

biote (BTMD) director awarded 130,000 options and deferred RSUs

Biote Corp. director Debra L. Morris reported compensation-related equity activity, including the exercise of derivative rights into 21,407 Class A Common Stock shares, bringing her direct holdings to 71,562 shares. She was also granted 130,000 stock options with a $2.20 exercise

Tone
Neutral 50/100
Event
Market update
Published
13 May 2026 22:09
Source
Stock Titan
Stock Titan Direct company coverage

biote Corp. (BTMD) director receives 195,000 stock options at $2.20 strike

biote Corp. director Marc D. Beer was granted 195,000 stock options with an exercise price of $2.20 per share. These options will vest on May 12, 2027, or the day before the company's 2027 annual meeting, contingent on his continuous service. This transaction is a grant and not a

Tone
Neutral 50/100
Event
Market update
Published
13 May 2026 22:09
Source
Stock Titan
Stock Titan Direct company coverage

biote (BTMD) director receives 130,000 options and 37,777 deferred RSUs

biote Corp. director Dana Lynn Jacoby was granted 130,000 stock options with an exercise price of $2.20 per share, vesting by May 12, 2027. She also received 37,777 Deferred Settlement RSUs, which are fully vested but settle in calendar year 2027 or upon her separation from servi

Tone
Neutral 50/100
Event
Market update
Published
13 May 2026 22:09
Source
Stock Titan
Stock Titan Direct company coverage

biote Corp. (BTMD) director Barrera receives 121,452 stock options at $2.20

Richard R. Barrera, a director and ten percent owner of biote Corp. (BTMD), was granted 121,452 stock options for Class A Common Stock with an exercise price of $2.20 per share. These options will vest on the earlier of May 12, 2027, or the day before the 2027 Annual Meeting of S

Tone
Neutral 50/100
Event
Market update
Published
13 May 2026 22:09
Source
Stock Titan
Stock Titan Direct company coverage

Bandera Partners reports 2.07M shares in biote Corp. (BTMD)

Bandera Partners LLC has filed an Amendment No. 3 to a Schedule 13G/A, reporting a beneficial ownership of 2,065,482 shares of biote Corp.'s Class A common stock, representing a 6.4% stake. The shares are held by Bandera Master Fund L.P., with Bandera Partners acting as the inves

Tone
Neutral 50/100
Event
Deals and strategy
Published
13 May 2026 20:09
Source
Stock Titan
Sahm Direct company coverage

Biote Q1 2026 Earnings Call: Complete Transcript

Biote reported an 8.3% revenue decline to $44.9 million in Q1 2026, primarily due to a 13.2% drop in procedure revenue caused by a voluntary product recall affecting hormone pellet supply. Despite this, dietary supplement revenue increased by 19.1%. The company maintains its 2026

Tone
Neutral 50/100
Event
Regulatory and legal
Published
07 May 2026 11:09
Source
Sahm